Updates

Texas Children's Cancer and Hematology Center

 Clinical Trials and Novel Therapies

As a recognized leader in clinical and laboratory research, we offer clinical trials and novel therapies for a wide range of children’s cancer and blood disorders.

Children treated through a clinical trial have better outcomes. Because of this, most of our patients are involved in a clinical trial or study. With over 250 active therapeutic clinical trials, our >350 researchers and 47 laboratories are pioneering the translation of discoveries to the clinic. As part of larger teams, our experts collaborate with the pharmaceutical industry and participate in major pediatric cancer and blood disorder cooperative clinical trial groups, like the Children’s Oncology Group (COG) and the Pediatric Brain Tumor Consortium (PBTC). Through these efforts, we are proud to offer the most advanced care possible. See below for our current and featured trials.

CD30 CAR T Cells, Relapsed CD30 Expressing Lymphoma (RELY-30)

Phase 1 immunotherapy trial using next generation CD30.CAR T cells for refractory lymphoma (Hodgkin or non-Hodgkin, including ALCL) (RELY 30).

Read More

For a complete list of clinical trials offered at Texas Children's Hospital, visit clinicaltrials.gov

Ranked #4 in Cancer

Proud to be ranked one of the best children’s cancer centers in the country by U.S. News & World Report for eight consecutive years.

See Rankings